Clinical Trial: Derivation and Validation of the Risk Evaluation Score for Pneumonia Involving Resistant Entities (RESPIRE)
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Pneumonia
Study Type: OBSERVATIONAL
Official Title: Derivation and Validation of the Risk Evaluation Score for Pneumonia Involving Resistant Entities (RESPIRE)
Brief Summary:
This is a single-center, non-profit observational study with two sequential phases: an initial retrospective phase followed by a prospective phase.Patients were enrolled during two consecutive, non-overlapping periods.The primary objective of the study is to derive a clinical predictive score for multidrug-resistant (MDR) pathogen-related pneumonia in patients diagnosed with pneumonia presenting to the Emergency Department and/or admitted to the hospital from the community.
Read more